Key Market Segments
By Product Type
-
Standalone 3D Tomosynthesis Systems
-
2D/3D Combination Tomosynthesis Systems
-
Software Solutions
-
Full-Field Digital Mammography (FFDM) Systems
By Technology
-
3D Mammography
-
Digital Mammography
-
Contrast-Enhanced Mammography
By Application
-
Breast Cancer Screening
-
Breast Cancer Diagnosis
-
Dense Breast Imaging
By End User
-
Hospitals
-
Diagnostic Imaging Centers
-
Research Institutions
-
Others (Ambulatory Surgical Centers (ASCs), Specialty Clinics, and Mobile Imaging Units)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key trends include the integration of AI in breast imaging, adoption of cloud-based radiology platforms, increased preference for 3D mammography, and digitization of imaging workflows.
North America leads the market, particularly the United States, due to high screening rates, technological advancement, and insurance coverage. Europe is the second-largest market, while Asia-Pacific is the fastest-growing region.
Top companies in the DBT market include Hologic, GE Healthcare, Siemens Healthineers, FUJIFILM Corporation, Canon Medical Systems, Philips Healthcare, and IMS Giotto S.p.A., among others.
Key drivers include the rising incidence of breast cancer, growing awareness of early diagnosis tools, increasing adoption of advanced imaging modalities, and favorable reimbursement policies in developed countries.
As of 2024, the global Digital Breast Tomosynthesis market is valued at USD 3.02 billion, driven by rising demand for early breast cancer detection and improved imaging technologies.
Get in Touch
